CE Stock Analysis — Celanese Corporation
Sector: Chemicals
AI Verdict
Celanese trades at 12x next year's earnings, cheap for the sector, but with -7.2% revenue growth the market is skeptical that its cost advantages will translate to a near-term rebound.
Competitive Moat
Celanese specializes in engineered polymers and acetyl products, with a defensible position built on proprietary chemical processes and long-term supply contracts with industrial customers. Its scale and integration across the acetyl chain create cost advantages that are difficult for smaller rivals to replicate.
Summary
Celanese trades at 12.0x forward earnings despite recent revenue contraction, making valuation a focal point.
Where It Stands
With a forward P/E of 12.0x versus a chemicals sector median of ~15x and trailing revenue down -7.2% year-over-year, the stock is priced below peers but faces growth headwinds.
Key Metrics
- Forward P/E: 12.0x
- Revenue Growth: -0.1%
- Dividend Yield: 0.00%
- 52-Week High: $70.70
- 52-Week Low: $35.13
Analyst Consensus
16 Buy · 9 Hold · 1 Sell (26 analysts)
Bull Case
The 12.0x forward P/E is a discount to the sector average, which could appeal to value-focused investors if earnings stabilize.
Bear Case
If the -7.2% revenue decline persists, even a modest P/E re-rating to the sector median would imply limited upside and potential downside if earnings expectations slip.
Catalyst to Watch
Watch for quarterly earnings updates—any sign of revenue stabilization or turnaround would be a key signal.